Article
A GIBAC-based selectivity strategy for the design of PDE5 inhibitors to minimize visual disturbances
2024-05-21
Abstract excerpt
Phosphodiesterase type 5 (PDE5) inhibitors are widely used in the treatment of various conditions, including erectile dysfunction and pulmonary hypertension. Despite their clinical efficacy, these drugs quite often cause visual disturbances due to off-target effects on Phosphodiesterase type 5 (PDE6) in the retina. This review explores the application of a general intermolecular binding affinity calculator (GIBAC)...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 471ea8ac-ce8a-5afd-a5a8-d1b8ab4086ff
- DOI
- 10.20944/preprints202405.1374.v1
